Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.15 | $0 | -$5M |
| 2026 Q1 | -0.22 | $0 | -$7M |
| 2025 Q4 | -0.43 | $0 | -$5M |
| 2025 Q3 | -0.82 | $0 | -$7M |
| 2025 Q2 | -0.31 | $0 | -$5M |
| 2025 Q1 | -0.29 | $0 | -$4M |
| 2024 Q4 |
| -0.14 |
| $0 |
| -$3M |
| 2024 Q3 | -0.18 | $0 | -$3M |